Article
Clinical tolerance in allogeneic hematopoietic stem cell transplantation
13 Apr 2011
Abstract excerpt
Allogeneic hematopoietic stem cell transplantation (HSCT) has been a curative therapeutic option for a wide range of immune hematologic malignant and non-malignant disorders including genetic diseases and inborn errors. Once in the host, allogeneic transplanted cells have not only to ensure myeloid repopulation and immunological reconstitution but also to acquire tolerance to host human leukocyte antigens via...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
